A. Morais (Maia, Portugal), A. Gogali (Ioannina, Greece)
Adalimumab treatment in patients with sarcoidosis: An open clinical trial using FDG-PET
N. Milman, N. Graudal, A. Jakobsen, B. Baslund (Copenhagen, Denmark)
|  |
Exercise intolerance, muscle strength impairment and fatigue in sarcoidosis patients
R. Marcellis, A. Lenssen, M. Elfferich, J. De Vries, G. Roox, M. Drent (Maastricht, Tilburg, Netherlands)
| |
The role of vitamin D3 in sarcoidosis (SA)
E. Puscinska, A. Kowalska, A. Skoczylas, J. Czerniawska, A. Goljan-Geremek, A. Rozy, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
| |
TACI and BAFFR expression in sarcoidosis
F. Bardaka, Z. Daniil, A. Mamara, K. Liadaki, F. Malli, K. I. Gourgoulianis, M. Speletas (Larissa, Greece)
| |
Sarcoidosis is associated with impaired endothelial function and arterial stiffness
G. Siasos, A. Rapti, E. Gialafos, E. Oikonomou, A. Kalianos, L. Papageorgiou, V. Anastasakos, D. Tsoukas, M. Zaromitidou, A. Plastiras, K. Vlasis, G. Marinos, V. Kouranos, O. Anagnostopoulou, C. Kostopoulos, C. Stefanadis (Athens, Greece)
| |
Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis
E. Gialafos, A. Rapti, G. Siasos, A. Kalianos, M. Zaromitidou, P. Tsirovassilis, N. Maniakos, E. Oikonomou, E. Peros, F. Katsaros, K. Vlasis, L. Velentza, G. Mpirmpa, E. Taktikou, C. Stefanadis (Athens, Greece)
| |
Role of genetic polymorphism in TNF α and TGF β gene in Polish patients with sarcoidosis
M. Czystowska, A. Goljan-Geremek, E. Puscinska, A. Skoczylas, P. Gaj, J. Ostrowski, D. Górecka (Warsaw, Poland)
| |
GST T1 and GST M1 gene polymorphisms in sarcoidosis
F. Coskun, M. Karkucak, D. Yilmaz, T. Yakut, E. Ege, E. Uzaslan (Bursa, Turkey)
| |
ACE gene I/D polymorphism in sarcoidosis
D. Yilmaz, M. Karkucak, F. Coskun, T. Yakut, E. Ege, E. Uzaslan (Bursa, Turkey)
|  |
Validation of sarcoidosis health questionnaire in a European population
S. de Boer, M. Wilsher (Auckland, New Zealand; , United Kingdom)
| |
Fatigue and exercise capacity in sarcoidosis
S. de Boer, J. Kolbe, M. Wilsher (Auckland, New Zealand; , United Kingdom)
| |
Laser evoked pain perception and daily experienced pain after sarcoidosis
I. Korenromp, E. Boezeman, C. Heijnen, J. Grutters, O. Vogels, J. van den Bosch (Nieuwegein, Utrecht, Netherlands)
| |
Association of tissue Doppler image derived A wave of tricuspid valve with DLCO
A. Rapti, E. Gialafos, K. Aggeli, V. Kouranos, A. Kalianos, G. Dionelis, G. Kaltsakas, T. Papaioannou, V. Kostantinos, C. Kostopoulos, R. Andrioti, C. Stefanadis (Athens, Greece)
| |
Bronchial hyperresponsiveness in patients with pulmonary sarcoidosis
O. Selroos, A. B. Löfroos (Karis, Finland; Vejbystrand, Sweden)
| |
Triamcinolone acetonide for intermittent treatment of sarcoidosis stage II
V. Karoukin, I. Kavalenka, L. Surkova (Minsk, Belarus)
| |
Clinical spectrum of Sarcoidosis in patients of Indian origin
L. Habib, D. Rosha (New Delhi, India)
| |
Monitoring disease progression in patients with biopsy proven cases of sarcoidosis: A survey
S. Iyer Kumar, H. Shigemitsu, O. Sharma (Los Angeles, United States Of America)
| |
Clinical determinants of six-minute walking test in pulmonary sarcoidosis
F. S. Oymak, C. Bol, H. Buyukoglan, A. Tiryaki Kanbay, R. Demir, I. Gulmez (Kayseri, Turkey)
| |
HRCT evaluation of thoracic sarcoidosis: What is the use?
T. Alfaro, J. Cemlyn-Jones, S. Freitas, C. Ruivo, L. Teixeira, C. Robalo-Cordeiro (Portugal)
| |
Does tobacco change sarcoidosis profile?
S. Freitas, J. Cemlyn-Jones, T. Alfaro, C. Robalo Cordeiro (Portugal)
| |